LMRI vs VCYT: stock comparison and AI forecast
Lumexa Imaging Holdings, Inc. (LMRI) and Veracyte, Inc. (VCYT) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
LMRI Lumexa Imaging Holdings, Inc.
- Price
- $13.21 +25.8% · 6M
- Market Cap
- $1.27B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
VCYT Veracyte, Inc.
- Price
- $24.00 -41.7% · 6M
- Market Cap
- $1.93B
- P/E Ratio
- 25.0x
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- VCYT is 1.5 times larger than LMRI by market capitalization ($1.93B against $1.27B).
- Over the last six months LMRI returned +25.8% and VCYT -41.7%.
- LMRI carries 1.94 times debt per unit of equity, against 0.10 times for VCYT.
- Both companies share the SEC industry classification Services-Medical Laboratories.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | LMRI | VCYT |
|---|---|---|
| Market Cap | $1.27B | $1.93B |
| P/E Ratio | – | 25.00x |
| P/B Ratio | 2.06x | 1.35x |
| EPS | – | $0.96 |
| Book Value/Share | $6.40 | $17.83 |
| Revenue/Share | – | $7.24 |
| FCF/Share | – | $2.01 |
Profitability & Margins
| Metric | LMRI | VCYT |
|---|---|---|
| ROIC | – | 6.7% |
| Gross Margin | – | 72.0% |
| Operating Margin | – | 17.1% |
| EBT Margin | – | 20.3% |
| Tax Rate | – | -7.3% |
Financial Health
| Metric | LMRI | VCYT |
|---|---|---|
| Current Ratio | 1.44x | 5.56x |
| Quick Ratio | – | 5.25x |
| D/E Ratio | 1.94x | 0.10x |
| Financial Leverage | 2.94x | 1.10x |
| Interest Coverage | 1.4x | – |
| Working Capital | $78M | $384M |
Cash Flow
| Metric | LMRI | VCYT |
|---|---|---|
| Operating Cash Flow | – | $174M |
| Free Cash Flow | – | $162M |
| Capital Spending | – | -$12M |
| OCF Growth YoY | – | 60.6% |
| FCF Growth YoY | – | 64.9% |
| FCF/Sales | – | 27.8% |
| CapEx/Sales | – | 2.0% |
Operational Efficiency
| Metric | LMRI | VCYT |
|---|---|---|
| Asset Turnover | – | 0.37x |
| Receivables Turnover | – | 10.2x |
| Fixed Assets Turnover | – | 23.4x |
| Days Sales Outstanding | – | 36 days |
Income Statement
| Metric | LMRI | VCYT |
|---|---|---|
| Total Revenue | – | $582M |
| Operating Income | – | $99M |
| R&D Expense | – | $110M |
| SG&A Expense | – | $325M |
Dividend & Shareholder Information
| Metric | LMRI | VCYT |
|---|---|---|
| Shares Outstanding | 96M | 80M |
| EPS Growth | – | 166.7% |
LMRI vs VCYT: stock comparison and AI forecast
Which is bigger, LMRI or VCYT?
VCYT is 1.5 times larger than LMRI by market capitalization ($1.93B against $1.27B).
Which stock performed better over the last six months, LMRI or VCYT?
Over the last six months LMRI returned +25.8% and VCYT -41.7%.
Which one does Intratio's AI model rank higher, LMRI or VCYT?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.